Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse
Between the Biotech Waves
00:00
The Resilience of the IPO Market
There's an element of is it the markets maturing given the developments, the approvals and revenues that were seen coming through. Are we seeing that level of maturity? Do you think nabbing reflected in it? And we're not going to see another exuberance from an IPO market in the next time this opens up or do you think this is going to be rinse repeat? It's going to happen again.
Play episode from 09:22
Transcript
